Study of Smith-Lemli-Opitz Syndrome

CompletedOBSERVATIONAL

Enrollment

130

Participants

Timeline

Start Date

September 13, 1998

Conditions

Smith-Lemli-Opitz Syndrome

Interventions

DRUG

Cholesterol Suspension

DRUG

CRH

DRUG

Cholesterol

Trial Locations (1)

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00001721 - Study of Smith-Lemli-Opitz Syndrome | Biotech Hunter | Biotech Hunter